Strikingly the lowest scores were measured at week 11 for both component scales and subscales although these results did not reach statistical significance.
← all excerpts
Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center Kiel.
1
—
—